The Federal Trade Commission (FTC) has cracked down on a health services provider accused of selling unqualified, sham health insurance plans through deceptive marketing and sales tactics. 

There are plenty of radiologists serving Medicare patients in the U.S., but the headcounts are unevenly distributed, and widely so.   

A medical AI startup in Omaha, Neb., has received the FDA’s blessing to market software for diagnosing prostate cancer on MRI scans.

MRI technologists serving patients who have difficulty understanding English may need to budget additional scanner time—especially when image quality largely depends on patients’ compliance with breathing instructions.

“With increasing global rates of Lyme disease, providing a new option for people to help protect themselves from the disease is more important than ever,” says Annaliesa Anderson, PhD, senior vice president and head of vaccine research & development at Pfizer.

The FDA’s Center for Devices and Radiological Health (CDRH) has updated the status of two previously disaccredited mammography operations, rehabilitating the reputation of one while showing the other in limbo.

Implementing an EHR cancer tracking system to review radiology reports for abnormal findings resulted in patients at one Veterans Affairs Hospital receiving their cancer diagnosis and treatment months earlier than those who were imaged before the system was put into place.

Point-of-care MRI is a worthwhile diagnostic option for emergency departments and ICUs concerned about wait or transport times to access fixed MRI for patients with neuroimaging needs.